Quantitative Investment Management’s Myriad Genetics MYGN Stock Holding History

Quantitative Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,762	Closed	-$430K	–	612
2020 Q4	$430K	Buy	+21,762	New	+$351K	0.03%	355
2020 Q2	–	Sell	-95,850	Closed	-$1.37M	–	625
2020 Q1	$1.37M	Buy	+95,850	New	+$2.02M	0.15%	166
2019 Q1	–	Sell	-30,300	Closed	-$880K	–	774
2018 Q4	$880K	Buy	+30,300	New	+$1.09M	0.05%	304
2018 Q3	–	Sell	-63,800	Closed	-$2.38M	–	793
2018 Q2	$2.38M	Buy	+63,800	New	+$2.15M	0.05%	335
2017 Q2	–	Sell	-36,400	Closed	-$698K	–	824
2017 Q1	$698K	Sell	36,400 -58,300	-62%	-$1.03M	0.01%	589
2016 Q4	$1.58M	Buy	+94,700	New	+$1.71M	0.04%	533
2016 Q1	–	Sell	-27,500	Closed	-$1.19M	–	871
2015 Q4	$1.19M	Sell	27,500 -35,400	-56%	-$1.5M	0.07%	328
2015 Q3	$2.36M	Buy	+62,900	New	+$2.23M	0.18%	145
2015 Q1	–	Sell	-9,600	Closed	-$326K	–	707
2014 Q4	$326K	Buy	9,600 +3,000	+45%	+$106K	0.05%	333
2014 Q3	$254K	Buy	+6,600	New	+$246K	0.05%	273
2014 Q2	–	Sell	-50,600	Closed	-$1.73M	–	583
2014 Q1	$1.73M	Buy	+50,600	New	+$1.57M	0.08%	167

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Quantitative Investment Management's MYGN Position: Q1 2021 in Review

Quantitative Investment Management sold out of Myriad Genetics (MYGN) in Q1 2021, closing a stake of 21,762 shares — an estimated $430K sold.

Quantitative Investment Management first reported a position in MYGN in Q1 2014 and held it in 11 quarters. The position peaked at $2.38M in Q2 2018. 197 funds tracked by Wall St. Rank hold MYGN as of Q1 2021.

Quantitative Investment Management reported no remaining Myriad Genetics position as of Q1 2021 after selling out during the quarter.
Quantitative Investment Management sold 21,762 Myriad Genetics shares in Q1 2021, an estimated $430K.
Quantitative Investment Management first reported a position in Myriad Genetics in Q1 2014 and held it in 11 quarters.
Quantitative Investment Management's Myriad Genetics position peaked at $2.38M in Q2 2018.
197 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.